This activity is jointly provided by Global Education Group and South Beach Symposium. This activity is supported by an educational grant from Allergan, Amen, Celgene, LEO Pharma, Pfizer, Sanofi-Regeneron, Valeant Pharmaceuticals and in-kind donations from Allergan and Galderma.
The educational design of this activity addresses the needs of physicians, nurses, and professional staff members of medical practices involved in the treatment of patients in dermatology, pediatric dermatology, plastic surgery, cosmetic surgery and other dermatologic medical procedures.
The South Beach Symposium is a four-day educational event delivering content on the newest therapies, technologies, procedures, and practice guidelines for physicians and practitioners in the field of clinical and aesthetic dermatology. SBS features highly interactive lectures and panel discussion presentations as well as live patient demonstrations of minimally invasive aesthetic treatments with injectables and devices. Now celebrating its 15th year, the 2017 South Beach Symposium will provide attendees with transferable skills and techniques that can easily be adapted to their current practice environment. As an attendee, we guarantee you will gain clinical pearls and techniques from SBS expert faculty that will change the way you practice and care for your patients.
After completing this activity, the participant should be better able to:
CLINICAL
AESTHETIC
PRACTICE MANAGEMENT
PEDIATRIC
The program agenda can be viewed here: https://www.southbeachsymposium.org/program-schedule.html.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and South Beach Symposium. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this live activity for a maximum of 30.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 30.75 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Attendees will be sent a claim credit email to the email address used for the symposium registration. The initial email will be sent from eval@conexsys.com on February 13th, 2017. It is recommended that you add this email address to your contacts list, so it will bypass your filters. Credit must be claimed within four weeks of the meeting, or by Sunday, March 19, 2017.
SBS will offer a 100% refund within 72 hours from time of purchase less applicable credit card processing fee. After 72 hours refunds will be less 50%. All refunds must be made in writing and post marked or tax stamped no later than 90 days before the event. No refund will be made if the request is made within 90 days of the educational event. Refunds will not be issued to non-show registrants. Substitutions are always welcome in lieu of cancellation for a $100.00 transit fee. No transfers to alternate events will be made if the request is submitted within 90 days of the original event.
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Speaker | Reported Financial Relationship |
| Glynis R. Ablon, MD | Nothing to disclose |
| Benjamin Ascher, MD | Nothing to disclose |
| Brian Berman, MD, PhD | Consultant: LEO, Halscion, Sensus, Medicis, DUSA, Dermira, Novartis, Onset, Galderma, Ferndale, Berg, Pharmaderm, Valeant, Biofrontera, Bayer, Clark, Medimetrix, Pulse, Celumigen, Aiviva, Exelis; Grant/Research Support: LEO, Exeltis, DUSA; Speaker’s Bureau: LEO, Halscion, Sensus, Medicis, DUSA, Dermira, Novartis, Onset, Galderma, Genentech, Ferndale, Biofrontera, Exeltis; Stockholder: TopMD, Dermira, Halscion, Berg |
| Diane S. Berson, MD | Consultant: Allergan, Galderma, P&G, Valeant, Revance, Taro, Aelaris. Stock: Top MD |
| Neal Bhatia, MD | Affiliations with Actavis, Allergan, Anacor, Aqua, Bayer, Biofrontera, BiopharmX, Dermira, Dusa, Exeltis, Ferndale, Foamix, Galderma, Intraderm, ISDIN, LaRoche-Posay, Leo, Novan, Novartis, PharmaDerm, Promius, Regeneron, Sanofi, SunPharma, and Valeant |
| Clay J. Cockerell, MD | Nothing to Disclose |
| David E. Cohen, MD, MPH | Stock: Dermira, Medimetriks; Consultant: Ferndale, Almiril, FIDE |
| Joel L. Cohen, MD | Consultant: Allergan, Merz, Galderma, Sciton, Lutronic. Grant/Research Support: Allergan, Merz, Galderma, Luteurc, Leo, Almay. Honoraria: Allergan, Merz, Galderma. |
| Doris J. Day, MD | Consultant: P&G, Speaker’s Bureau: Allergan, Galderma, Merz, Lumenis |
| Adam DeGraide | CEO: Crystal Clear Digital Marketing |
| James Q. Del Rosso, DO | Spouse: Novartis: Pharmaceutical Representative at Novartis in Respiratory Division; Self: Consultant: Aqua/Almirall, Allergan, Anacor/Pfizer, Bayer, BioPharmX, Celgene, Dermira, Ferndale, Foamix, Galderma, LeoPharma, Novan, Novartis, Pharmaderm, Promius, Sebacia, SunPharma, Unilever, Valeant, Viamet; Clinical Research: Allergan, Bayer, BioPharmX, Celgene, Cutanea, Dermira, Galderma, Genentech, LeoPharma, Novan, Promius, Sebacia, SunPharma, Valeant; Honoraria: Aqua, Allergan, Anacor/Pfizer, Bayer, BioPharmX, Celgene, Dermira, Ferndale, Foamix, Galderma, LeoPharma, Novan, Novartis, Pharmaderm, Promius, Sebacia, SunPharma, Taro, Unilever, Valeant, Viamet; Speaker’s Bureau: Aqua/Almirall, Allergan, Bayer, Celgene, Ferndale, Galderma, Genetech, LeoPharma, Novartis, Pharmaderm, Promius, SunPharma, Taro, Valeant. |
| Barry DiBernardo, MD, FACS | Consultant: Cynosure, Thermi, Vision Medical, Merz; Grant/Research Support: Cynosure, Thermi, Defanage, Nutrafol, Mertz; Honoraria: Cynosure, Thermi; Speaker’s Bureau: Thermi, Cynosure, Merz; Stock Shareholder: Cynosure; Royalty: Elsevier |
| Zoe D. Draelos, MD | Nothing to Disclose |
| Julius Few, MD | Consultant: Allergan, Galderma, Venus, Zeltique, Sindau |
| Louis R. Frisina, BA, MPA | Nothing to disclose |
| Michael H. Gold, MD | Consultant and Advisor Board: Aerolase, Allergan, Alma Lasers, Almirall, Anacor Pharmaceuticals, Aquvit Pharm, Bayer Health Care, Celgene, Clairsonic, SkinCeuticals, L’Oreal, Croma, DefanAge, DUSA Pharmaceuticals, EndyMed, Erchonia, Exeltis, Galderma, Intra Derm, Invasix, Johnson & Johnson, Lumenis, Merz, Neothetics, Novartis, Pierre Fabre, Prollenium, Promius, Sente, Sinclair Pharma, Smith & Nephew, Syneron-Candela, Suneva, Thermi Aesthetics, Valeant, Viviscal, Zimmer |
| David J. Goldberg, MD, JD | Consultant/Independent Contractor: Almirall, Thermi, Aerolase; Grant/Research Support: Galderma, Merz, InMode, Novon, Sienna Labs, Cutera, Cynosure, LRO, Focus; Speaker’s Bureau: Endymed, Merz, Alma, Cutera; Stock Shareholder: Aquavit |
| Mercedes E. Gonzalez, MD | Speakers Bureau and Honoraria: Pierre Fabre Pharmaceuticals, Encore Dermatology |
| David Herold, MD | Nothing to disclose |
| Bruce E. Katz, MD | Grant/Research support: Cynosure, Merz, Galderm, Alma, Neocutis. Honoraria: Cynosure, Allergan, Merz, Galderma, Neocutis |
| Mark D. Kaufmann, MD | Stock Options: Modernizing Medicine, Inc. |
| Jonette E. Keri, MD, PhD | Consultant/Independent Contractor: Roche Pharmaceuticals |
| Leon Kircik, MD | Abbott Laboratories: Speaker; Aclaris: Advisory Board; Acambis: Investigator; Allergan, Inc.: Investigator, Advisory Board, Speaker, Consultant; Almirall: Consulting, Advisory Board; Amgen, Inc.: Consultant, Investigator, Speaker; Anacor Pharmaceuticals: Investigator, Consultant, Advisory Board; Assos Pharma: Speaker; Astellas Pharma US, Inc.: Investigator, Speaker; Asubio: Investigator; Berlex Laboratories (Bayer Healthcare Pharmaceuticals): Investigator; Biogen-Idec: Advisory Board; Biolife: Investigator; Biopelle: Investigator; Boehringer-Ingleheim: Investigator; Beckinridge Pharma: Investigator; Colbar: Consultant, Advisory Board; Celgene: Investigator, Advisory Board; Centocor, Inc.: Investigator; Cellceutix: Investigator; Cipher: Consultant, Speaker, Advisory Board; Coherus: Investigator; CollaGenex: Investigator, Consultant, Speaker; Combinatrix: Investigator; Connetics Corporation: Advisory Board, Consultant, Speaker; Coria: Investigator; Dermavant: Investigator; Dermira: Investigator; Dermik Laboratories: Speaker; Dow Pharmaceutical Sciences, Inc.: Investigator; Dusa: Investigator; Embil Pharmaceuticals: Speaker; Eli Lilly: Investigator; EOS: Advisory Board; Exeltis: Advisory Board, Consultant, Speaker, Investigator; Ferndale Laboratories, Inc.: Advisory Board, Investigator; Galderma Laboratories, LP: Consultant, Speaker, Advisory Board, Investigator; Genentec, Inc.: Advisory Board, Speaker, Investigator, Consultant; GlaxoSmithKline, PLC: Investigator; Health Point, LTD: Investigator; Idera: Investigator; Intendis: Advisory Board, Consultant, Investigator; Innocutis: Speaker, Advisory Board; Innovail: Speaker; Isdin: Advisory Board, Consultant; Johnson & Johnson: Consultant, Investigator, Advisory Board, Speaker, Stockholder ; Laboratory Skin Care, Inc.: Consultant; Leo: Investigator, Consultant, Speaker; L’Oreal: Investigator, Speaker; 3M: Speaker, Investigator; Maruho: Investigator; Medical International Technologies: Consultant; Merck: Consultant, Investigator; Medicis Pharmaceutical Corp.: Investigator; Merz: Consultant; Nano Bio: Advisory Board, Investigator; Novartis AG: Investigator, Consultant; Noven Pharmaceuticals: Investigator; Nucryst Pharmaceuticals Corp: Investigator; Obagi: Investigator; Onset: Investigator, Speaker; OrthoNeutrogena: Speaker, Investigator, Advisory Board, Consultant; Promius: Investigator, Consultant, Advisory Board; PediaPharma: Speaker; QLT, Inc.: Investigator; PharmaDerm: Investigator, Speaker; Pfizer: Investigator; PuraCap: Consultant; Quinnova: Investigator Advisory Board; Quatrix: Investigator; serono (Merck Serono International SA): Speaker; SkinMedica, Inc.: Consultant, Investigator, Advisory Board, Speaker; Stiefel Laboratories, Inc.: Speaker, Investigator, Advisory Board, Consultant; Sun Pharma: Consultant, Advisory Board, Speaker; Taro: Consultant/Speaker; TolerRx: Investigator; Triax: Speaker, UCB: Investigator, Speaker, Consultant; Valeant Pharmaceuticals, Intl: Advisory Board, Investigator, Consultant, Speaker; Warner-Chilcott: Advisory Board, Speaker, Investigator; XenoPort: Investigator; ZAGE: Consultant. |
| Mark G. Lebwohl, MD | Employee of Mount Sinai Medical Center which receives research funds from: AbbVie, Amgen, Anacor, Boehringer Ingleheim, Celgene, Eli Lilly, Janssen Research & Development, LLC, Kadmon, Medimmune/Astra Zeneca, Novartis, Pfizer, and ViDac. |
| Henry W. Lim, MD | Grant/Research Support: Ferndale, Estee Lauder, Allergan |
| Z. Paul Lorenc, MD, FACS | Nothing to Disclose |
| Stephen Mandy, MD | Consultant/Independent Contractor: Proctor & Gamble, Almirall; Honoraria: Sinclair; Speaker’s Bureau: Merz, Galderma. |
| Seth Matarasso | Consultant: Allergan |
| Flor Mayoral, MD | Nothing to Disclose |
| Art McOmber | Nothing to Disclose |
| Sharon McQuillan, MD | Consultant: Sciton, Great Healthworks; Honoraria: MMI Institute. |
| Gary D. Monheit, MD | Consultant: Allergan, Revance, Galderma, Merz, Sueva; Grant/Research Support: Galderma, Teoxane, Allergan, Suneva, CROMA, Alphaeon |
| Mark S. Nestor, MD | Investigator/Grant: Actavis, Allergan, Almirall, Annacor Pharmaceuticals, Brickell Biotech, Cosmederm Biosciences, CROMA Pharma GmbH, Cynova Laboratories, DUSA Pharmaceuticals, Erchonia Corporation, Evolus, Inc., Exeltis USA Dermatology, Ferndale Laboratories, Galderma Laboratories, IFC, S.A., La Lumiere, LLC, LEO Pharma, Neothetics, Sinclair Pharma; Consultant/Honoraria: Almirall, Bayer Healthcare, Erchonia Corporation, Ferndale Laboratories, Galderma Laboratories, La Lumiere, LLC, Neothetics, Sensus Healthcare, Sinclair Pharma, Strathspey Crown, Thermiaesthetics; Advisory Board: allergan, Almirall, Bayer, Castle Biosciences, Ferndale Laboratories, Galderma, La Lumiere, LLC, LEO Pharma, Neothetics, Sensus Healthcare, Sinclair Pharma, Thermiaesthetics |
| Michael L. Nestor, ISD | Nothing to Disclose |
| Anna Nichols, MD, PhD | Nothing to Disclose |
| Margaret C. Oliviero, MSN, ARNP-BC | Consultant: 3 Gen, Caliber I.D., Heine, Canfield, Molescope |
| David M. Pariser, MD | Honoraria/Grant/Research Funding: Bickel Biotechnology, Biofrontera AG, Celgene Corporation, Dermira, DUSA Pharmaceuticals, LEO Pharma, Novartis Pharmaceuticals, Pfizer, Promius, Regeneron, TheraVida, Valeant Pharmaceuticals International, Abbott Laboratories, Amgen, Bickel Biotechnology, Celgene Corporation, Eli Lilly, Novo Nordisk A/S, Ortho Dermatologics, Pfizer, Photocure ASA, Stiefel a GSK company; Principal Investigator/No Compensation: Peplin, Inc. |
| Jason Pozner, MD | Speaker’s Bureau: Sciton, Thermi, Cynosure Lutronic; Stock: Sciton, Cytrellis, Revance |
| Harold S. Rabinovitz, MD | Consultant: Caliber I.D., 3 Gen Inc., Heine, MOLEsCOPE |
| Marta I. Rendon, MD | Speaker’s Bureau: Obagi, Galderma, Allergan, SkinMedia |
| Darrell S. Rigel, MD, MS | Beiersdorf Inc: Advisory Board, Honoraria; Ferndale: Advisory Board, Honoraria; Foamix: Board of Directors; Genentech: Advisory Board, Honoraria; LEO Pharma US: Advisory Board, Honoraria; Neutrogena: Consultant, Honoraria; Johnson and Johnson US: Advisory Board, Honoraria; Novartis: Speaker, Honoraria; Proctor & Gamble: Consultant, Honoraria; Valeant: Consultant, Honoraria. |
| Theodore Rosen, MD | Nothing to disclose |
| Frank Rosengaus, MD | Nothing to disclose |
| William I. Roth, MD | Consultant/Honoraria: Sensus Healthcare |
| Neil S. Sadick, MD | Honoraria: Venus Concept |
| Lawrence A. Schachner, MD | Consultant: Medimetriks, Brickel Labs, Lexington; Grant/Research Support: Medimetriks, Berg, Astellas, Scioderm; Stock: Top MD |
| Elaine Siegfried, MD | Honoraria: Pierre Fabre, Celegene |
| Darlene L. Tomlinson, MBA, MHL | Nothing to disclose |
| Abel Torres, MD, JD | Nothing to disclose |
| Antonella Tosti, MD | Books/Journals: Springer, CRC Press, Karger |
| David L. Wagener, MBA, CPA | Nothing to disclose |
| Susan H. Weinkle, MD | Allergan: Consultant, Grant/Research Support, Honoraria, Speaker’s Bureau; Galderma: Consultant, Honoraria, Speaker’s Bureau. Alphera: Grant/Research Support; DermAvane: Stock Shareholder |
| Cheryl Whitman | Nothing to disclose |
| Name of Planner | Reported Financial Relationship |
| Ashley Marostica, RN, MSN | Nothing to disclose |
| Lindsay Borvansky | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
| Laura Gilsdorf | Nothing to disclose |
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and South Beach Symposium do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
